News | Magnetic Resonance Imaging (MRI) | September 14, 2018

Philips Launches Ingenia Ambition X 1.5T MR

Ingenia Ambition X combines fully sealed BlueSeal magnet technology and workflow innovations for a step-change in productivity

Philips Launches Ingenia Ambition X 1.5T MR

September 14, 2018 — Philips announced the launch of the Ingenia Ambition X 1.5T magnetic resonance imaging (MRI) scanner. It is the latest advance in the Ingenia MRI portfolio, which comprises fully-digital MRI systems, healthcare informatics and a range of maintenance and life cycle services for integrated solutions that empower a faster, smarter and simpler path to enabling a confident diagnosis. The first commercial installation of the Ingenia Ambition X was recently completed at Spital Uster Hospital, a major provider of extended primary healthcare in the canton of Zurich, Switzerland. The Ingenia Ambition X is CE marked and has received 510(k) clearance from the U.S. Food and Drug Administration (FDA).

In radiology, meeting the need for high productivity and an improved patient experience while ensuring excellence in imaging can be daunting. The perception is often that MR represents a trade-off between productivity and image quality. The Ingenia Ambition X provides what Philips calls leading-edge MRI capabilities while helping to increase overall productivity, combining its BlueSeal magnet with innovations that can help reduce downtime, enable single-operator workflow and speed up exam times by up to 50 percent.

Incorporating Philips' BlueSeal fully-sealed magnet, the Ingenia Ambition X is the world's first MR system to enable helium-free operations [3], reducing the chance of potentially lengthy and costly disruptions, and virtually eliminating dependency on a commodity with an unpredictable supply. The fully-sealed system does not require a vent pipe and is around 900 kg lighter than its predecessor, significantly reducing the siting challenges presented by conventional magnets and lowering construction costs.

"We are very proud to be the first hospital in the world to offer this new cutting-edge, resource-friendly MRI technology to our patients," said Andreas Steinauer, M.D., chief radiologist at Spital Uster Hospital, Switzerland. "With the new Philips Ingenia Ambition X our patients can have the best of two worlds: leading MRI technology with a smaller footprint. This new leaner platform will allow more sites to deliver advanced MRI technology to their patients, helping to improve patient care."

The Ingenia Ambition X includes a range of new features that combine to deliver a step-change in productivity, according to Philips. With Philips' EasySwitch solution, the BlueSeal's magnetic field can be easily turned off if an item becomes stuck in the bore. Once the problem is resolved, an in-house or Philips technician can initiate an automated ramp-up to bring the magnet back to field, minimizing operational downtime. A conventional MR can require two staff to manage daily operations. The Ingenia Ambition X combines guided patient setup and Adaptive Intelligence-driven SmartExam analytics for automatic planning, scanning and processing. This frees up time to enable a single operator to manage the full scan from the patient's side with just a single touch of a button.

Philips Compressed SENSE is an advanced acceleration application that reduces exam times by up to 50 percent. In addition, Philips VitalEye is a unique approach to detecting patient physiology and breathing movement. VitalEye technology and algorithms intelligently extract signs of breathing – allowing routine exam set-up time to occur in less than a minute, even for less experienced operators. Together, these innovations help to standardize and speed up workflow, allowing clinicians to focus on the patient.

Read the article "Miami Cardiac and Vascular Institute Implements Philips Ingenia Ambition X 1.5T MRI"

For more information: www.usa.philips.com/healthcare

Related Content

Advances in long-length digital radiography are creating opportunities for visualization during spinal surgery, as well as pre- and post-operatively. Image courtesy of Fujifilm Medical Systems

Advances in long-length digital radiography are creating opportunities for visualization during spinal surgery, as well as pre- and post-operatively. Image courtesy of Fujifilm Medical Systems

Feature | Digital Radiography (DR) | July 19, 2019 | By Greg Freiherr
Recent advances in...
Two brain metastases from primary lung cancer are contrast enhanced in the brain of a 61-year-old male. Speakers at AHRA 2019 will state that ProHance and other macrocyclic MR agents present a very low risk to patients. Images courtesy of Bracco

Two brain metastases from primary lung cancer are contrast enhanced in the brain of a 61-year-old male. Speakers at AHRA 2019 will state that ProHance and other macrocyclic MR agents present a very low risk to patients. Images courtesy of Bracco

Feature | Contrast Media | July 18, 2019 | By Greg Freiherr
Macrocyclic contrast agents have the best safety profile of all the magnetic resonance (MR) contrast media that are n
AAPM 2019 Features More Than 40 Presentations on ViewRay's MRIdian MRI-guided Radiotherapy
News | Image Guided Radiation Therapy (IGRT) | July 16, 2019
ViewRay Inc. announced that the company's MRIdian System is the focus of more than 40 abstracts selected by the...
FDA Approves Bayer's Gadavist Contrast for Cardiac MRI in Adult Coronary Artery Disease Patients
Technology | Contrast Media | July 15, 2019
The U.S. Food and Drug Administration (FDA) has approved Gadavist injection for use in cardiac magnetic resonance...
Fluke Biomedical Introduces RaySafe 452 Survey Meter
Technology | Radiation Dose Management | July 11, 2019
Radiation measurement often requires different devices for varying applications, adding to the cost and complexity of...
Insightec's Exablate Neuro Approved With GE Signa Premier MRI in U.S. and Europe
News | Focused Ultrasound Therapy | July 10, 2019
GE Healthcare and Insightec announced U.S. Food and Drug Administration (FDA) approval and CE mark for Insightec’s...
SimonMed Imaging Implements ProFound AI for 3-D Tomosynthesis
News | Mammography | July 10, 2019
Arizona-based SimonMed Imaging announced their implementation of the first U.S. Food and Drug Administration (FDA)-...
Infervision Releases InferTEST Program at SIIM 2019
News | Artificial Intelligence | July 08, 2019
Infervision announced their InferTEST program at the recent Society for Imaging Informatics in Medicine (SIIM)...
Delta T1 Maps Provide Quantitative, Automated Solution to Assess Brain Tumor Burden
News | Neuro Imaging | July 05, 2019
Imaging Biometrics LLC (IB) a subsidiary of IQ-AI Ltd., is highlighting a recently published study in the American...
Medic Vision Wins Japanese PMDA Clearance for iQMR Image Reconstruction Solution
News | Magnetic Resonance Imaging (MRI) | July 05, 2019
Medic Vision Imaging Solutions announced that its 3-D iterative image reconstruction technology for shortening magnetic...